Medicus Pharma Ltd.

NASDAQ: MDCXW · Real-Time Price · USD
0.68
-0.01 (-0.90%)
At close: Aug 18, 2025, 3:44 PM
0.68
0.00%
After-hours: Aug 18, 2025, 04:00 PM EDT

Medicus Pharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q3 2022
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Sep 30, 2022
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a 26.53K 26.03K 25.92K n/a n/a n/a
Gross Profit
n/a n/a -26.53K -26.03K -25.92K n/a n/a n/a
Operating Income
-5.11M -2.36M -3.03M -4.04M -1.77M -1.87M -223.93K -256.11K
Interest Income
23.79K 73.97K 55.96K n/a n/a n/a n/a n/a
Pretax Income
-5.09M -2.21M -2.98M -4.13M -1.78M -2.61M -2.93M -366K
Net Income
-5.09M -2.21M -2.98M -4.13M -1.78M -2.61M -2.93M -366K
Selling & General & Admin
3.11M 1.03M 2.22M 2.95M 1.43M 1.84M 184.05K 77.59K
Research & Development
2M 1.33M 783.77K 1.07M 314.97K 35.45K 39.88K 178.52K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
5.11M 2.36M 3M 4.02M 1.75M 1.87M 223.93K 256.11K
Interest Expense
n/a n/a 9.06K 88.24K 8.97K n/a 302.58K 128.87K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
-5.11M -2.36M -3.03M -4.04M -1.77M -1.87M -223.93K -256.11K
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
12.24M 11.82M 9.51M 8.17M 8.08M 8.08M 8.08M 1.88M
Shares Outstanding (Diluted)
12.24M 11.82M 9.51M 8.17M 8.08M 8.08M 8.08M 1.88M
EPS (Basic)
-0.42 -0.19 -0.31 -0.51 -0.22 -0.32 -0.36 -0.19
EPS (Diluted)
-0.42 -0.19 -0.31 -0.51 -0.22 -0.32 -0.36 -0.19
EBITDA
-5.09M -2.29M -2.95M -4.02M -1.75M -2.61M -2.62M -237.13K
EBIT
-5.09M -2.29M -2.97M -4.04M -1.77M -2.61M -2.62M -237.13K
Depreciation & Amortization
n/a n/a 26.53K 26.03K 25.92K n/a n/a n/a